Virtu Financial LLC Jounce Therapeutics, Inc. Transaction History

Virtu Financial LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 01, 2023	BUY	$0.9 - $1.85 $103,404 - $212,553	114,894 Added 1015.41%	126,209 $233,000
Q4 2022 Feb 15, 2023	BUY	$0.64 - $1.99 $7,241 - $22,516	11,315 New	11,315 $13,000
Q1 2019 Apr 12, 2019	SELL	$3.43 - $6.87 $113,172 - $226,675	-32,995 Closed	0 $0
Q4 2018 Jan 16, 2019	BUY	$2.69 - $6.71 $88,756 - $221,396	32,995 New	32,995 $111,000
Q2 2018 Jul 30, 2018	SELL	$7.27 - $21.88 $206,308 - $620,910	-28,378 Closed	0 $0
Q2 2018 Jul 30, 2018	BUY	$7.27 - $21.88 $206,308 - $620,910	28,378 New	28,378 $217,000

720K

Ticker JNCE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 51,694,200
Description
Jounce Therapeutics, Inc., a clinical-stage immunotherapy company, develops therapies for the treatment of cancer. The company develops vopratelimab, a clinical-stage monoclonal antibody, which is in Phase II clinical trial that binds to and activates the Inducible T cell CO-Stimulator, a protein on the surface of T cells found in various solid ...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.